MicroRNA Dysregulation in Gastric Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|7|1273-1284

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.7, 2013-02, pp. : 1273-1284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased Expression of MicroRNA-221 in Gastric Cancer and Its Clinical Significance

By Liu K   Li G   Fan C   Diao Y   Wu B   Li J  

The Journal of International Medical Research, Vol. 40, Iss. 2, 2012-03 ,pp. : 467-474

Field House Publishing

Access to resources Recommend Favorite

MicroRNA Dysregulation in Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 9, 2018-01 ,pp. : 1000-1009

Bentham Science Publishers

Access to resources Recommend Favorite

microRNA, Cancer and Cancer Chemoprevention

By  

Current Molecular Pharmacology, Vol. 5, Iss. 3, 2012-11 ,pp. : 362-371

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA Dysregulation in Esophageal Neoplasia: The Biological Rationale for Novel Therapeutic Options

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1236-1241

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 4, 2010-12 ,pp. : 289-305

Bentham Science Publishers

Access to resources Recommend Favorite